Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Non-Current Debt (2024 - 2025)

Celularity has reported Non-Current Debt over the past 2 years, most recently at $36.5 million for Q2 2025.

  • Quarterly results put Non-Current Debt at $36.5 million for Q2 2025, changed N/A from a year ago — trailing twelve months through Jun 2025 was $36.5 million (changed N/A YoY), and the annual figure for FY2024 was $35.9 million, changed.
  • Non-Current Debt for Q2 2025 was $36.5 million at Celularity, roughly flat from $36.5 million in the prior quarter.
  • Over the last five years, Non-Current Debt for CELU hit a ceiling of $36.5 million in Q1 2025 and a floor of $35.9 million in Q4 2024.